Leucine

Generic Name
Leucine
Brand Names
Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
Drug Type
Small Molecule
Chemical Formula
C6H13NO2
CAS Number
61-90-5
Unique Ingredient Identifier
GMW67QNF9C
Background

An essential branched-chain amino acid important for hemoglobin formation.

Indication

Indicated to assist in the prevention of the breakdown of muscle proteins that sometimes occur after trauma or severe stress.

Associated Conditions
Hypoalbuminemia
Associated Therapies
Amino acid supplementation

Rapid Antidepressant Effects of Leucine

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2017-03-14
Last Posted Date
2023-01-26
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
16
Registration Number
NCT03079297
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Texas Southwestern Medical Center, Dallas, Texas, United States

L-leucine in Diamond Blackfan Anemia Patients

Phase 2
Conditions
Interventions
First Posted Date
2015-03-11
Last Posted Date
2015-03-11
Lead Sponsor
Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogache
Target Recruit Count
30
Registration Number
NCT02386267
Locations
๐Ÿ‡ท๐Ÿ‡บ

Federal Scientific Clinical Centre of Pediatric Hematology Oncology Immunology n.a. Dmitry Rogachev, Moscow, Russian Federation

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

First Posted Date
2011-05-30
Last Posted Date
2022-12-02
Lead Sponsor
Northwell Health
Target Recruit Count
55
Registration Number
NCT01362595
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Boston Children's Hospital, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Missouri-Columbia Women's and Children's Hospital, Columbia, Missouri, United States

๐Ÿ‡บ๐Ÿ‡ธ

UT Southwestern Medical Center, Dallas, Texas, United States

and more 8 locations

Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis

Terminated
Conditions
First Posted Date
2001-04-11
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Target Recruit Count
36
Registration Number
NCT00014768
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Utah School of Medicine, Salt Lake City, Utah, United States

Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion

First Posted Date
2000-06-05
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Target Recruit Count
96
Registration Number
NCT00005889
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Baylor College of Medicine, Houston, Texas, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath